论文部分内容阅读
目的探讨C-反应蛋白(CRP)在重症支原体(MP)肺炎早期诊断和治疗的临床意义。方法对25例重症MP肺炎(实验组)的CRP与同期住院的26例普通支原体肺炎(对照组)的CRP进行比较分析。结果实验组患儿平均CRP达40mg/L,标准差10mg/L;而对照组患儿平均CRP为15mg/L,标准差12mg/L。实验组患儿CRP明显升高,与普通支原体肺炎组患儿差异有统计学意义,P<0.01。结论 C-反应蛋白作为早期重症MP肺炎诊断和治疗的应用参考指标,具有确切的临床意义。
Objective To investigate the clinical significance of C-reactive protein (CRP) in the early diagnosis and treatment of severe mycoplasma pneumonia. Methods The CRP of 25 cases of severe MP pneumonia (experimental group) and 26 cases of common mycoplasma pneumonia (control group) hospitalized in the same period were compared and analyzed. Results The mean CRP in the experimental group was 40 mg / L with a standard deviation of 10 mg / L, while the mean CRP in the control group was 15 mg / L with a standard deviation of 12 mg / L. CRP in experimental group was significantly higher than that in common mycoplasma pneumonia group, P <0.01. Conclusion C-reactive protein as an early diagnosis and treatment of severe MP pneumonia with reference indicators, with the exact clinical significance.